Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Error in Text

Error in Text Letters Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts out-of-pocket costs for tafamidis borne by many patients, (Falk). which is directly related to its excessively high list price. Corresponding Author: Sarah A. M. Cuddy, MBChB, Nuclear Medicine Department, Brigham and Women’s Hospital, 75 Francis St, L1, Boston, MA Jerry H. Gurwitz, MD 02115 (scuddy1@bwh.harvard.edu). Mathew S. Maurer, MD Published Online: April 22, 2020. doi:10.1001/jamacardio.2020.0863 Conflict of Interest Disclosures: Dr Cuddy has received a Junior Investigator Author Affiliations: Meyers Primary Care Institute, Worcester, Massachusetts grant from Pfizer and salary support from charitable donations from the David (Gurwitz); Division of Geriatric Medicine, University of Massachusetts Medical Shapira Foundation. Dr Falk has received consulting fees from Ionis School, Worcester (Gurwitz); Center for Cardiac Amyloidosis, Division of Pharmaceuticals, Alnylam Pharmaceuticals, and Caelum Biosciences as well as Cardiology, Department of Internal Medicine, Columbia University Irving research funding from GlaxoSmithKline, Akcea, and Pfizer. No other disclosures Medical Center, New York, New York (Maurer). were reported. Corresponding Author: Jerry H. Gurwitz, MD, Meyers Primary Care Institute, 1. Gurwitz JH, Maurer MS. Tafamidis—a pricey therapy for a not-so-rare 385 Grove St, Worcester, MA 01605 (jerry.gurwitz@umassmed.edu). condition. JAMA Cardiol. Published online January 8, 2020. doi:10.1001/ jamacardio.2019.5233 Published Online: http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Error in Text

JAMA Cardiology , Volume 5 (7) – Jul 20, 2020

Error in Text

Abstract

Letters Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts out-of-pocket costs for tafamidis borne by many patients, (Falk). which is directly related to its excessively high list price. Corresponding Author: Sarah A. M. Cuddy, MBChB, Nuclear Medicine Department, Brigham and Women’s Hospital, 75 Francis St, L1, Boston, MA Jerry H. Gurwitz, MD 02115 (scuddy1@bwh.harvard.edu). Mathew S. Maurer, MD Published Online: April 22, 2020....
Loading next page...
 
/lp/american-medical-association/error-in-text-xvM61hDwNm
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2020.1722
Publisher site
See Article on Publisher Site

Abstract

Letters Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts out-of-pocket costs for tafamidis borne by many patients, (Falk). which is directly related to its excessively high list price. Corresponding Author: Sarah A. M. Cuddy, MBChB, Nuclear Medicine Department, Brigham and Women’s Hospital, 75 Francis St, L1, Boston, MA Jerry H. Gurwitz, MD 02115 (scuddy1@bwh.harvard.edu). Mathew S. Maurer, MD Published Online: April 22, 2020. doi:10.1001/jamacardio.2020.0863 Conflict of Interest Disclosures: Dr Cuddy has received a Junior Investigator Author Affiliations: Meyers Primary Care Institute, Worcester, Massachusetts grant from Pfizer and salary support from charitable donations from the David (Gurwitz); Division of Geriatric Medicine, University of Massachusetts Medical Shapira Foundation. Dr Falk has received consulting fees from Ionis School, Worcester (Gurwitz); Center for Cardiac Amyloidosis, Division of Pharmaceuticals, Alnylam Pharmaceuticals, and Caelum Biosciences as well as Cardiology, Department of Internal Medicine, Columbia University Irving research funding from GlaxoSmithKline, Akcea, and Pfizer. No other disclosures Medical Center, New York, New York (Maurer). were reported. Corresponding Author: Jerry H. Gurwitz, MD, Meyers Primary Care Institute, 1. Gurwitz JH, Maurer MS. Tafamidis—a pricey therapy for a not-so-rare 385 Grove St, Worcester, MA 01605 (jerry.gurwitz@umassmed.edu). condition. JAMA Cardiol. Published online January 8, 2020. doi:10.1001/ jamacardio.2019.5233 Published Online:

Journal

JAMA CardiologyAmerican Medical Association

Published: Jul 20, 2020

References